VP
Veer Pal Singh
About Veer Pal Singh
Data last updated:
Veer Pal Singh is a Director at Copmed Pharmaceuticals Private Limited (since 2009), Director at Relax Pharmaceuticals Private Limited (since 1997) and Director at Sirmour Green Environ Limited (since 2011). The companies operate in Pharma, Machinery and Equipment and Packaging. The 2 current companies with reported revenue have a combined latest revenue of ₹653 Cr; the largest is Copmed Pharmaceuticals Private Limited at ₹438 Cr (FY 2025). Earlier, Veer Pal Singh was a Director at Qualitek Starch Private Limited (2019–2024) and Director at Pharmaforce Medex Private Limited (2019–2024) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Copmed Pharmaceuticals Private Limited U74899DL1988PTC033151 | Director | 31 Jul 2009 | 1988 | ₹438 Cr (FY 2025) | Active |
 Relax Pharmaceuticals Private Limited U24231DL1997PTC461314 | Director | 31 Jul 1997 | 1997 | ₹216 Cr (FY 2024) | Active |
 Sirmour Green Environ Limited U41000HP2010PLC031422 | Director | 01 Sep 2011 | 2010 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Qualitek Starch Private Limited U15134DL2019PTC461318 | Director | 06 Nov 2019 | 2019 | ₹13.17 Cr (FY 2025) | Active |
| Pharmaforce Medex Private Limited U24230DL2019PTC461316 | Director | 20 Nov 2019 | 2019 | ₹7.70 Cr (FY 2025) | Active |
 Mediforce Healthcare Private Limited U51397DL2001PTC461317 | Director | 01 Feb 2008 | 2001 | ₹105 Cr (FY 2024) | Active |
| Medipack Innovations Private Limited U28113DL2012PTC237207 | Director | 21 Jun 2012 | 2012 | ₹66.94 Cr (FY 2025) | Active |
 Sirmour Remedies Private Limited U15311HP1989PTC009770 | Director | 20 Aug 2005 | 1989 | ₹98.10 Cr (FY 2025) | Active |
| Newgen Starch Llp AAP-8363 | Designated Partner | 08 Jul 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Veer Pal Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhay Kumar Srivastava | 08040683 | Copmed Pharmaceuticals Private Limited , Relax Pharmaceuticals Private Limited | Director |
| Akhlas Ahmed | 08973480 | Copmed Pharmaceuticals Private Limited , Relax Pharmaceuticals Private Limited | Director |
| Anju Kumari Jha | 08141260 | Copmed Pharmaceuticals Private Limited , Relax Pharmaceuticals Private Limited | Director |
| Bhupendra Kaushik | 07016552 | Copmed Pharmaceuticals Private Limited , Relax Pharmaceuticals Private Limited | Director |
| Jagmohan Sharma | 10734653 | Copmed Pharmaceuticals Private Limited | Whole-Time Director |
| Vikash Sharma | 10734663 | Relax Pharmaceuticals Private Limited | Whole-Time Director |
| Anil Munjal | 02478832 | Sirmour Green Environ Limited | Director |
| Brijeshwar Dutt Tyagi | 01283494 | Sirmour Green Environ Limited | Director |
| Gian Singh Chauhan | 08576055 | Sirmour Green Environ Limited | Nominee Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Veer Pal Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veer Pal Singh
Veer Pal Singh currently holds 3 directorships: Copmed Pharmaceuticals Private Limited (Director, since 31 Jul 2009, revenue ₹438 Cr (FY 2025)); Relax Pharmaceuticals Private Limited (Director, since 31 Jul 1997, revenue ₹216 Cr (FY 2024)); Sirmour Green Environ Limited (Director, since 01 Sep 2011).
Veer Pal Singh was first appointed on 31 Jul 1997 as Director at Relax Pharmaceuticals Private Limited. The most recent appointment on record is 20 Nov 2019 at Pharmaforce Medex Private Limited.
The 2 current companies of Veer Pal Singh that report revenue have a combined latest revenue of ₹653 Cr: Copmed Pharmaceuticals Private Limited ₹438 Cr (FY 2025); Relax Pharmaceuticals Private Limited ₹216 Cr (FY 2024).
Veer Pal Singh held 6 earlier board appointments: Qualitek Starch Private Limited (Director, 06 Nov 2019 to 25 Jul 2024); Pharmaforce Medex Private Limited (Director, 20 Nov 2019 to 24 Jul 2024); Mediforce Healthcare Private Limited (Director, 01 Feb 2008 to 27 Jul 2017); Medipack Innovations Private Limited (Director, 21 Jun 2012 to 13 Aug 2018); Sirmour Remedies Private Limited (Director, 20 Aug 2005 to 25 Jul 2017); and 1 more.
The current boards of Veer Pal Singh's companies include Abhay Kumar Srivastava (Copmed Pharmaceuticals Private Limited), Akhlas Ahmed (Copmed Pharmaceuticals Private Limited), Anju Kumari Jha (Copmed Pharmaceuticals Private Limited), Bhupendra Kaushik (Copmed Pharmaceuticals Private Limited), Jagmohan Sharma (Copmed Pharmaceuticals Private Limited), Vikash Sharma (Relax Pharmaceuticals Private Limited), among others.